GPC1 and pancreatic neoplasm: Recently, it was shown that in a preclinical xenograft model, glypican 1 (GPC1) targeted immunotoxins, derived from a functional domain of Pseudomonas endotoxin A, inhibit pancreatic tumor growth via degradation of internalized GPC1, downregulation of Wnt signaling, and inhibition of protein synthesis [284].